By Dr. Mercola
A new study reported in the New England Journal of Medicine suggests that increased awareness and improved treatments rather than provider-recommended breast imaging are the main force in reducing the breast cancer death rate.
The study, medical experts say, is the first to assess the benefit of provider-recommended breast imaging in the context of the modern era of breast cancer treatment.
While it is unlikely to settle the debate over provider-recommended breast imaging — and experts continue to disagree about the value of the test — it indicates that improved treatments with hormonal therapy and other targeted drugs may have, in a way, washed out most of provider-recommended breast imaging’s benefits by making it less important to find cancers when they are too small to feel…
[su_button url=”https://tdinj.com/articles/provider-recommended breast imaging/The-Breast-Cancer-Screening-Mistake-Millions-Make.pdf” target=”blank” style=”soft” background=”#3f80a8″]Read the Full Article[/su_button]